Roles of μ-opiod receptors in development of tolerance to diisopropylfluorophosphate (DFP)

Keyphrases

• Anti-acetylcholinesterase 9%
• Benzil 9%
• Chewing Movement 18%
• Cholinergic System 18%
• Cortex 18%
• Days of Treatment 9%
• Diisopropylfluorophosphate 100%
• Hippocampus 18%
• Induced Tremors 36%
• Knock-in Mouse Model 18%
• M2 muscarinic Receptor 27%
• Muscarinic Receptor Binding 27%
• Muscarinic Receptors 18%
• No Significant Difference 9%
• Opiod Receptors 100%
• Opioid Receptors 72%
• Opioidergic System 18%
• Pirenzepine 9%
• Receptor Knockout 54%
• Regulatory Mechanism 9%
• Striatal 9%
• Striatum 18%
• Subcutaneous Injection 9%
• Tolerance Development 18%
• Treatment Duration 9%
• Wild Mice 36%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylcholinesterase 9%
• Cholinergic Receptor Stimulating Agent 18%
• Dyflos 100%
• Knockout Mouse 18%
• Muscarinic M1 Receptor 18%
• Muscarinic M2 Receptor 27%
• Muscarinic Receptor 9%
• Opiate Receptor 90%
• Pirenzepine 9%
• Quinuclidinyl Benzilate 9%
• Subcutaneous Injection 9%
• Wild Type Mouse 36%

Neuroscience

• 3-Quinuclidinyl Benzilate 10%
• Acetylcholinesterase 10%
• Cholinergic 20%
• Hippocampus 20%
• Muscarinic Acetylcholine Receptor 10%
• Muscarinic M1 Receptor 20%
• Muscarinic M2 Receptor 30%
• Pirenzepine 10%
• Receptor Binding 30%
• Striatum 20%
• Tremor 40%
• δ -Opioid Receptor 100%